Working to Eradicate Gynecologic Cancers

Ginger J. Gardner, MD

Attending Physician
Memorial Sloan Kettering Cancer Center
1275 York Avenue
H-1313
New York, NY
USA 10065

Papers:
77 Outcomes of patients with stage I endometrial cancer in the sentinel lymph node era 88 Impact of obesity on sentinel lymph node mapping in patients with newly diagnosed uterine cancer undergoing robotic surgery 104 Improvement in rates of cytoreduction to no residual for stages IIIB-IV ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach and individualized surgeon feedback 109 Cost-effectiveness analysis of conventional laparoscopic versus robotically assisted laparoscopic adnexal surgery for benign indications performed by gynecologic oncologists 183 Radical hysterectomy: programmatic change to reduce laparotomy rate while maintaining oncologic outcome for early stage cervical cancer 244 Sentinel lymph node mapping in patients with vulvar malignancies using indocyanine green and near-infrared imaging: preliminary detection rate experience 292 Combined preoperative and extended pharmacologic venous thromboembolic prophylaxis in patient undergoing surgery for advanced adnexal malignancies 302 Outcomes for patients with advanced epithelial ovarian cancer treated with adjuvant chemotherapy at a regional network facility compared to the central campus 315 Cost-effectiveness analysis of robotically assisted radical hysterectomy for newly diagnosed uterine cervical cancer 446 Predictive value of the age-adjusted Charlson comorbidity index on perioperative complications and survival in patients undergoing surgery for advanced ovarian cancer Moderator Introductory Remarks